Your MACEPA Malaria Minute: Innovations in the pipeline

By Sarah Pickersgill
Advocacy and Communications Officer, MACEPA, and Global Health Corps Fellow

New from PATH

PATH released its second Malaria Learning Series publication, The PATH Innovation Pipeline for Malaria. This report builds the case for continued investment in innovation in the malaria space and gives an overview of PATH’s innovation pipeline for malaria, which includes promising projects in vaccines, diagnostics, drugs (both developing new drugs and using existing drugs in new ways), and system and service innovations.


 


Malaria community surveillance training

MACEPA’s Zambia surveillance team is conducting a community surveillance refresher training in Kalomo District, Southern Province, Zambia, this week. A total of 234 community health workers are expected to undergo the training. Pictured are community health workers performing a pre-test reading of rapid diagnostic test results.

 

 

 

 

 


In the news

A study titled Return on Innovation released by the Global Health Technologies Coalition and Policy Cures Research of Australia is making a new case for investing in global health. The study found that US investments in global health research and development created 200,000 new American jobs and returned $33 billion to the US economy between 2007 and 2015. (via NPR)

For more on the economic angle, Devex reporter Catherine Cheney interviews malaria experts in a detailed look at making the case for malaria eradication in a tight budgetary environment.

The “Seeing Malaria in Asia Pacific” project comes to Singapore’s National Library. Photographer Pearl Gan and Professor J. Kevin Baird are presenting this photo exhibit to raise awareness of the malaria burden effecting underrepresented populations across Asia. (via Huffington Post)

In addition to providing critical data tools to help track malaria in Zambia, Tableau is now also collaborating with NGOs in Myanmar to help track the progress of humanitarian and economic development programs. (via The Straits Times)

In Ghana, the Private Sector Malaria Prevention program looks to get bednets on the shelves of shops and markets. In support of Ghana’s national malaria control strategy, which distributes free nets, this commercial component aims to fill in gaps like intermittent net replacement and general advertising. (via Johns Hopkins Center for Communication Programs)

A handheld NIR spectrometry system from Global Good is undergoing field trials in Kenya, Namibia, and Laos. The system works by paring a smartphone app with a handheld NIR spectrometer in order to identify counterfeit drugs by spectral signature. (via IEEE)

A recent study conducted in Burkina Faso reviews the frequency at which RDTs reveal a false-positive malaria diagnosis. In this study, RDTs reported 29.7 percent false-positives; prompting a call for the development of new tools to determine other causes of fever in malaria endemic areas. (via Malaria Journal)

Jörg Reinhardt, chairman of the Novartis board of directors, discusses the dangers of antimicrobial resistance and how world leaders can learn from current malaria efforts to head-off artemisinin resistance. (via Project Syndicate)

← Back to previous page

Leave a Reply

Your email address will not be published.